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Introduction
In thalassemia patients heart failure remains the main
cause of mortality. High cardiac output state due to
chronic anaemia is a significant determinant of cardiomy-
opathy, in particular in thalassemia intermedia (TI)
patients (a moderate form, not transfusion dependent).
Hypoxia and volume overload are known stimuli for
plasma N-terminal fragment of proBNP (NT-proBNP)
raise. Nevertheless, NT-proBNP role in clinical manage-
ment of thalassemia patients has not been fully investi-
gated.
Purpose
Aim of our study was to assess the role of NT-proBNP
assay in a large prospective cohort of thalassemia patients,
evaluated by cardiovascular magnetic resonance (CMR).
Methods
215 thalassemia patients (39 TI, age 38 ± 12 years, 51%
females) and 176 thalassemia major patients (TM, age 30
± 9 years, 54% females) underwent consecutively CMR
(1.5 T) and blood sampling for plasma assay of NT-
proBNP. Myocardial iron overload was assessed using a
multislice multiecho T2* approach able to provide the
global T2* value in the left ventricle. Cine sequences were
obtained to quantify biventricular morphological and
functional parameters. RV and LV volumes and ejection
fraction (EF) were evaluated by a semi-automatic software
(Mass Plus, Leiden, NL).
Results
NT-proBNP levels were comparable in TI and TM patients
(139 ± 146 ng/L versus 108 ± 122 ng/L; P = NS). Mean
haemoglobin levels (P < 0.0001) and myocardial iron
overload (P = 0.001) were significantly lower in TI than in
TM patients. Left end-diastolic volume (P < 0.0001) and
mass indexes (P = 0.002), right ejection fraction (P <
0.0001) and biatrial area indexes (P = 0.006) were signif-
icantly higher in TI vs. TM patients. In TI patients NT-
proBNP was negatively associated with mean haemo-
globin levels (r = -0.6, P = 0.008) and positively with left
and right atrial area indexes (r = 0.6, P = 0.001 and r = 0.4,
P = 0.007, respectively), left and right end diastolic vol-
ume indexes (r = 0.5, P = 0.003 and r = 0.3, P = 0.04,
respectively) and left ventricular mass index (r = 0.4, P =
0.007). In TM patients no significant correlation was
found between NT-proBNP levels and morphological biv-
entricular parameters. In both groups no significant corre-
lation was found between NT-proBNP levels and
myocardial iron overload.
Conclusion
Hypoxia and volume overload due to chronic anaemia,
more pronounced in TI patients, justify the correlation
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between NT-proBNP and high cardiac output-related
findings in TI patients. These data suggest a) a potential
routinary use of NT-proBNP as marker of high cardiac out-
put cardiomyopathy in the anaemic thalassemia popula-
tion; b) to reconsider the current haematological/
transfusional management in TI patients.Page 2 of 2
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